Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-01-31
1997-05-06
Reamer, James H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546169, A61K 3147
Patent
active
056271930
ABSTRACT:
The present invention relates to quinoline-4-carbonylguanidine derivative represented by formula (1) ##STR1## and pharmaceutically acceptable salt thereof, a process for producing the same, and a Na.sup.+ /H.sup.+ exchanger inhibitor containing the compound as an active ingredient. The compounds of the present invention are useful as an agent for treating or preventing various diseases by hyperfunction of the Na.sup.+ /H.sup.+ exchanger and as a diagnostic agent for these diseases.
REFERENCES:
patent: 4680299 (1987-07-01), Hesson
patent: 4684652 (1987-08-01), Dubroeucq et al.
patent: 4711890 (1987-12-01), Dubroeucq et al.
patent: 4970214 (1990-11-01), Murase et al.
patent: 5071987 (1991-12-01), Raulfs et al.
patent: 5204329 (1993-04-01), Ackerman et al.
patent: 5373024 (1994-12-01), Lang et al.
Rex Mahnensmith et al, The Plasma Membrane Sodium-Hydrogen Exchanger and Its Role in Physiological and Pathophysiological Processes, Circulation Research, Jun. 1985, vol. 56, No. 6, pp. 773-788.
Dieter Rosskopf et al, Membrane Sodium-Proton Exchange and Primary Hypertension, Hypertension, vol. 21, No. 5, May 1993, pp. 608-617.
Steven Dennis et al, Effects of Proton Buffering and of Amiloride Derivatives on Reperfusion Arrhythmias in Isolated Rat Hearts, Circulation Research, vol. 66, No. 4, Apr. 1990, pp. 1156-1159.
Masayuki Mitsuka et al, Na.sup.+ -H.sup.+ Exchange Inhibitors Decrease Neointimal Formation After Rat Carotid Injury, Circulation Research, vol. 73, No. 2, Aug. 1993, pp. 269-275.
Jun Fukuzawa et al, Supplement I, Circulation, vol. 86, No. 4, Oct. 1992, pp. 1-176--1-177.
Martin Schwartz et al, Effect of Cell Spreading on Cytoplasmic pH in Normal and Transformed Fibroblasts, Proc. Natl. Acad. Sci. USA, vol. 86, Jun. 1989, pp. 4525-4529.
Sanna Rosengren et al, Migration-associated Volume Changes in Neutrophils Facilitate the Migratory Process in Vitro, American Journal of Physiol., vol. 267, 1994, pp. C1623-C1632.
Thomas Kleyman et al, Amiloride and Its Analogs as Tools in the Study of Ion Transport, J. Membrane Biol., vol. 105, 1988, pp. 1-21.
Dr. H. A. Staab, Syntheses Using Heterocyclic Amides (Azolides), Angew. Chem. Internat. Edit., vol. I, No. 7, 1962, pp. 351-367.
Theodora Greene, Protective Groups in Organic Synthesis, 1981, 87-287.
Arnold Weissberger et al, Quinolines, Part I, 1977, pp. 124-319.
Berichte, 20, pp. 277-280, 1887.
W. Pfitzinger, Chinolinderivate aus Isatins aure, J. Prakt. Chem., 33, 100, 1886.
A.R. Katritzky et al, Advances in Heterocyclic Chemistry, vol. 18, 1975, pp. 1-58.
C.D. Foster et al, Characterization of Na.sup.+ -H.sup.+ Exchange in Segments of Rat Mesenteric Artery, American Physiological Society, 262, 31, 1992, pp. H-1651--H1656.
M.J.A. Walker et al, The Lanbeth Conventions: Guidelines for the Study of Arrhythmias in Ischaemia, Infarction, and Reperfusion, Cardiovascular Research, vol. 22, 1988 pp. 447-455.
Banno Hitoshi
Fujiwara Junya
Hosoya Junko
Kitamori Takashi
Mori Haruki
Mitsui Toatsu Chemicals Inc.
Reamer James H.
LandOfFree
Quinoline-4-carbonylguanidine derivatives, process for producing does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinoline-4-carbonylguanidine derivatives, process for producing, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline-4-carbonylguanidine derivatives, process for producing will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2132905